Clinical Trial

Efficacy of Cerebello-spinal Direct Current Stimulation (csDCS) on Functional Mobility in Chronic Stroke Patients

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 18, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this clinical trial is to determine if cerebello-spinal direct current stimulation (csDCS) is effective in treating gait disorders in individuals with chronic stroke. Additionally, the trial seeks to evaluate the safety of this technique. The primary objectives include: Investigating whether cerebello-spinal direct current stimulation improves gait and functional mobility in participants with chronic stroke. Assessing any potential side effects associated with the method. Researchers will conduct a comparative analysis between cerebello-spinal direct current stimulation and a sham procedure (which mimics the stimulation without any actual effect) to assess its effectiveness in addressing gait disorders and enhancing mobility. Participants in the trial will: Undergo cerebello-spinal direct current stimulation combined with treadmill training or a sham procedure with treadmill training daily over a two-week period.
Trial Details
NCT Number NCT07073287
Lead Sponsor Universidade Federal de Pernambuco
Collaborators: Universidade Federal do Rio de Janeiro, Conselho Nacional de Desenvolvimento Científico e Tecnológico
Conditions Stroke Rehabilitation, Gait Disorders, Neurologic, tDCS
Enrollment 30 participants
Start Date 2024-05-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-18